u 78517f has been researched along with verapamil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, S; Kimura, M; Maeda, K | 1 |
| Gloy, J; Greger, R; Hug, MJ; Meyer, TN; Pavenstädt, H; Schollmeyer, P | 1 |
2 other study(ies) available for u 78517f and verapamil
| Article | Year |
|---|---|
Cytosolic calcium increase in coronary endothelial cells after H2O2 exposure and the inhibitory effect of U78517F.
Topics: Animals; Calcium; Catalase; Cells, Cultured; Chromans; Coronary Vessels; Cytosol; Diltiazem; Endothelium, Vascular; Free Radical Scavengers; Hydrogen Peroxide; In Vitro Techniques; Lipid Peroxidation; Nifedipine; Piperazines; Swine; Verapamil | 1992 |
Hydrogen peroxide increases the intracellular calcium activity in rat mesangial cells in primary culture.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidotes; Antioxidants; Calcium; Catalase; Cells, Cultured; Chromans; Cytoplasm; Deferoxamine; Dithiothreitol; Flufenamic Acid; Glomerular Mesangium; Hydrogen Peroxide; Lanthanum; Nickel; Piperazines; Pyruvic Acid; Rats; Sulfhydryl Reagents; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 1996 |